|
|
Volumn 37, Issue 5 PART 2, 2008, Pages 902-911
|
|
Role of genetics in psychiatric treatment;Apport de la génétique aux traitements psychiatriques
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ANXIOLYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARBAMAZEPINE;
CLOZAPINE;
CYTOCHROME P450;
DIAZEPAM;
FLUVOXAMINE;
HALOPERIDOL;
IMIPRAMINE;
LITHIUM;
NEUROLEPTIC AGENT;
NORTRIPTYLINE;
OLANZAPINE;
OPIATE;
PAROXETINE;
PSYCHOTROPIC AGENT;
QUINIDINE;
RISPERIDONE;
SERTRALINE;
VENLAFAXINE;
ACETYLATION;
BIPOLAR DISORDER;
DRUG METABOLISM;
GENETIC ANALYSIS;
GENETIC POLYMORPHISM;
GENETIC VARIABILITY;
HUMAN;
MENTAL DISEASE;
MENTAL HEALTH CARE;
PHARMACOGENETICS;
PRESCRIPTION;
SCHIZOPHRENIA;
SHORT SURVEY;
TREATMENT RESPONSE;
|
|
EID: 43049145425
PISSN: 07554982
EISSN: None
Source Type: Journal
DOI: 10.1016/j.lpm.2008.01.015 Document Type: Short Survey |
|
Times cited : (2)
|
|
References (27)
|
